Merck Aktie

136,95 EUR -1,35 EUR -0,98 %

15:45:13

STU

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.60,20 Mrd. EUR

KGV22,19Div. Rendite1,53%

WKN659990

ISINDE0006599905

SymbolMKGAF

Merck Aktien News

Sortieren:Datum Meistgelesen

08.01.24ZacksMerck (MRK) Begins Pivotal Studies on Four Cancer Candidates

08.01.24BenzingaHealth Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics

08.01.24ZacksThe Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group

08.01.24MarketWatchMerck to pay 118% premium to buy cancer drugmaker Harpoon Therapeutics

05.01.24ZacksTop Analyst Reports for Merck, Salesforce & Philip Morris

05.01.24BenzingaP/E Ratio Insights for Merck & Co

04.01.24Business TimesMerck looks to join the obesity drug frenzy

04.01.24BenzingaMcDonald's Revenues Expected To Increase, Plus Merck And More On CNBC's 'Final Trades'

03.01.24ZacksWhy the Market Dipped But Merck (MRK) Gained Today

01.01.24Financial TimesMerck bid for Japanese chip materials maker triggers state-backed fund deal

29.12.23MotleyFoolModerna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?

27.12.23ZacksWhy Merck (MRK) Outpaced the Stock Market Today

26.12.23BenzingaWhat the Options Market Tells Us About Merck & Co

26.12.23ZacksMerck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag

25.12.23BenzingaLooking Into Merck & Co's Recent Short Interest

21.12.23ZacksIs Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?

20.12.23ZacksMerck (MRK) Stock Moves -1.06%: What You Should Know

19.12.23ZacksMerck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer

14.12.23ZacksMerck (MRK) Stock Declines While Market Improves: Some Information for Investors

14.12.23FOX BusinessMerck-Moderna vaccine with Keytruda cuts risk of skin cancer relapse or death by half, data shows

13.12.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

05.12.23EQS GroupEQS-Adhoc: Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide

27.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

24.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

22.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

21.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

15.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

14.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

13.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

03.11.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

25.10.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

24.10.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

23.10.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

16.10.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

27.09.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

21.09.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18.09.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

14.09.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

11.09.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

08.09.23EQS GroupEQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Merck News

Merck News: auf dieser Seite finden Sie alle Merck News und Nachrichten zur Merck Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Merck News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Merck News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.